Determining cost and placement decisions for moderate complexity NAATs for tuberculosis drug susceptibility testing

BACKGROUND: Access to drug resistant testing for tuberculosis (TB) remains a challenge in high burden countries. Recently, the World Health Organization approved the use of several moderate complexity automated nucleic acid amplification tests (MC-NAAT) that have performance profiles suitable for pl...

Descripción completa

Detalles Bibliográficos
Autores principales: Malhotra, Akash, Thompson, Ryan, De Vos, Margaretha, David, Anura, Schumacher, Samuel, Sohn, Hojoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10449112/
https://www.ncbi.nlm.nih.gov/pubmed/37616318
http://dx.doi.org/10.1371/journal.pone.0290496

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10449112/
https://www.ncbi.nlm.nih.gov/pubmed/37616318
http://dx.doi.org/10.1371/journal.pone.0290496

Ejemplares similares